Correlation Between Y MAbs and Zentalis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Y MAbs and Zentalis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Y MAbs and Zentalis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Y mAbs Therapeutics and Zentalis Pharmaceuticals Llc, you can compare the effects of market volatilities on Y MAbs and Zentalis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Y MAbs with a short position of Zentalis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Y MAbs and Zentalis Pharmaceuticals.
Diversification Opportunities for Y MAbs and Zentalis Pharmaceuticals
-0.07 | Correlation Coefficient |
Good diversification
The 3 months correlation between YMAB and Zentalis is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Y mAbs Therapeutics and Zentalis Pharmaceuticals Llc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zentalis Pharmaceuticals and Y MAbs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Y mAbs Therapeutics are associated (or correlated) with Zentalis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zentalis Pharmaceuticals has no effect on the direction of Y MAbs i.e., Y MAbs and Zentalis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Y MAbs and Zentalis Pharmaceuticals
Given the investment horizon of 90 days Y mAbs Therapeutics is expected to generate 0.97 times more return on investment than Zentalis Pharmaceuticals. However, Y mAbs Therapeutics is 1.03 times less risky than Zentalis Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Zentalis Pharmaceuticals Llc is currently generating about -0.03 per unit of risk. If you would invest 488.00 in Y mAbs Therapeutics on September 2, 2024 and sell it today you would earn a total of 704.00 from holding Y mAbs Therapeutics or generate 144.26% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Y mAbs Therapeutics vs. Zentalis Pharmaceuticals Llc
Performance |
| Timeline |
| Y mAbs Therapeutics |
| Zentalis Pharmaceuticals |
Y MAbs and Zentalis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Y MAbs and Zentalis Pharmaceuticals
The main advantage of trading using opposite Y MAbs and Zentalis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Y MAbs position performs unexpectedly, Zentalis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zentalis Pharmaceuticals will offset losses from the drop in Zentalis Pharmaceuticals' long position.| Y MAbs vs. Revolution Medicines | Y MAbs vs. Black Diamond Therapeutics | Y MAbs vs. Passage Bio | Y MAbs vs. Bluebird bio |
| Zentalis Pharmaceuticals vs. Tff Pharmaceuticals | Zentalis Pharmaceuticals vs. Eliem Therapeutics | Zentalis Pharmaceuticals vs. Inhibrx | Zentalis Pharmaceuticals vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance |